BiotechTube
Home/Pipeline/Oral Antibiotic

Oral Antibiotic

Bacterial infections

ANDA Filed/Pre-approvalActive

Key Facts

Indication
Bacterial infections
Phase
ANDA Filed/Pre-approval
Status
Active
Company
Dawah Pharmaceuticals

About Dawah Pharmaceuticals

Dawah Pharmaceuticals is a commercial-stage generic drug company employing a capital-light, partnership-driven model to bring essential medicines to market. Its strategy centers on identifying and filling supply gaps for sterile injectable and ophthalmic products by collaborating with top-tier international CMOs, primarily for U.S. market entry. Backed by leadership with decades of healthcare experience, the company is building a diverse pipeline targeting therapeutic areas like critical care, oncology, and CNS disorders, with several product launches projected from 2026 onward. Dawah's approach combines U.S. regulatory expertise with cost-effective global manufacturing to improve drug access and affordability.

View full company profile

Therapeutic Areas

Critical CareOncologyMental HealthInfectious DiseaseOphthalmologyCardiovascularMetabolic DisordersNeurologyPain Management

Other Bacterial infections Drugs

DrugCompanyPhase
Azithromycin Preparationscspc-pharmaceuticalCommercial
Penem Preparationscspc-pharmaceuticalCommercial
Various Penicillin/Cephalosporin Productscspc-pharmaceuticalCommercial
Nemonoxacin Malate CapsulesZhejiang MedicineCommercial
Generic Portfolio Expansion - Anti-infectivesAlkaloid AD SkopjeRegulatory Submission
Clindamycin Phosphate InjectionViwitCommercial
Levofloxacin Hydrochloride InjectionViwitCommercial
Meropenem-VaborbactamSciClone PharmaceuticalsCommercial (in China)
Vibativ® (telavancin)Cleo Life SciencesApproved
Penicillin V APIBiotikaCommercial
Sterile Injectable Antibiotics PortfolioSteripharmaApproved
XAB05/XAB06XenotheraPreclinical